Latest news:

23rd ODM+ RCT shows benefit in Obese Patients

A newly published randomised controlled trial (RCT) is the 23rd to reinforce the important contribution of oesophageal Doppler monitoring (ODM+). The study evaluates haemodynamic management in obese surgical patients. Obesity... read more

Haemodynamic Management improves patients’ safety

In the United States, at least $5 billion in hospital costs are related to AKI, and the true costs are likely much, much higher.” Silver et al, Nephron 2017;137:297–301

ODM has been used in more than 1 million surgical and ICU patients globally

Quick and easy to use

Significantly reduces the annual global cost of treating surgical AKI

Implementation costs can be recouped by avoiding an AKI in fewer than 5 patients haemodynamically optimised

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:

 

Registered in England & Wales Company No: 1691369